Description
An antiparasitic compound and a derivative of artemisinin; induces mortality in adult wild-type and pfatp6-mutant P. falciparum but the efficacy is decreased in the mutants (IC50s = 8.2 and 13.5 nM, respectively); reduces parasitemia in P. falciparum-infected monkeys and P. berghei-infected mice (CD50s = 7.1 and 55 mg/kg, respectively); reduces the worm burden of S. mansoni trematodes in mice at doses ranging from 200-500 mg/kg
Formal name: (3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin
Synonyms: (+)-Artemether|SM-224
Molecular weight: 298.4
CAS: 71963-77-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antiparasitics|Anthelmintics||Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Natural Products||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Malaria||Research Area|Infectious Disease|Parasitic Diseases|Schistosomiasis